Matt Pike brings extensive pharmacy background to new position
SPARTANBURG, S.C. – Smith Drug Company (SDC) has announced that Matthew Pike has been named to the newly-created position of Associate Vice President of Strategy, Industry Relations. In this role, Pike will work with Smith Drug Company to develop and operationalize strategy designed to maximize efficiencies and market share. Pike will also leverage his background as a resource for industry relations.
“To have someone of Matt’s caliber on our team is a tremendous asset,” said Jeff Foreman, RPh, President, Smith Drug Company. “Matt brings a great deal of experience and knowledge of the industry. Our team has tremendous depth and expertise already, but Matt’s arrival strengthens it even more. Smith Drug Company is poised for success against the challenges that lie ahead, and our customers will benefit from this.”
James C. Wilson Jr. to retire after 30 years with the company
SPARTANBURG, S.C. — The Board of Directors of J M Smith Corporation has confirmed Philip J. Ryan, III as Chief Financial Officer and appointed Kevin Welch to the role of Chief Technology Officer. Ryan will also assume the role of Treasurer following the retirement of James C. Wilson, Jr. on October 1, 2017. Wilson has been employed with the company since 1987, serving first as controller before being elected Treasurer and then being named CFO.
“These appointments are significant steps on the path towards leadership excellence and operational excellence. Both Phil and Kevin are highly respected experts in their fields,” said Alan Turfe, Chairman and CEO, J M Smith Corporation. “Their passion for our organization and their vision for moving it forward are impressive. I am looking forward to working with them in their expanded roles.
Lena Jouran to lead finance team
SPARTANBURG, S.C. – Smith Drug Company (SDC) has announced that Lena Jouran has joined the company as Divisional Vice President, Finance. She will support both Smith Drug Company and Burlington Drug Company in her new role. Jouran replaces Kyle Waltz, who has accepted the position of Vice President Corporate Controller at the J M Smith Corporation.
“Lena brings with her an extensive background in managing the finance complexities of the pharmacy supply chain,” said Jeff Foreman, RPh, President, Smith Drug Company. “We are excited to have her join the team and expect she will be a tremendous asset to our organization.”
Alan Turfe to Lead J M Smith Corporation
SPARTANBURG, S.C. – The Board of Directors of J M Smith Corporation has named A. Alan Turfe as the new CEO and Chairman of the Board, effective March 1, 2017, following the retirement of long-time Chairman and CEO William R. Cobb. Turfe was selected by the board following a nationwide search, and brings a wealth of experience in the life sciences, medical device, e-commerce and automotive industries.
“In a pool of incredibly qualified candidates, Alan demonstrated the leadership skills, business acumen and background best suited to lead J M Smith Corporation into the future,” said board member Terry Cash, who chaired the search committee. “Alan is growth-minded and believes, as we do, that the future is bright for J M Smith Corporation. We believe he will both honor the proud history of this organization while leading it through the dynamic times ahead.”
Burlington Drug Company has become a subsidiary of J M Smith Corporation as of January 1, 2017. Burlington Drug Company will continue to manage all operations, customer service and sales functions out of the current facility in Milton, Vermont. This business combination will enable J M Smith Corporation to expand market offerings to the important Northeast market of the United States, while giving Burlington Drug Company customers access to a variety of new tools, services and products that will create additional growth opportunities for their businesses.